基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 ANTI-CPEB4 (N-TERM) POLYCLONAL ANTIBODY Anti-CPEB4 (N-term) Polyclonal Antibody
  • Anti-CPEB4 (N-term) Polyclonal Antibody

Anti-CPEB4 (N-term) Polyclonal Antibody

Anti-CPEB4 (N-term) Polyclonal Antibody
960.00 50ul 起订
1600.00 100ul 起订
北京 更新日期:2025-12-30

北京索莱宝科技有限公司

VIP10年
联系人:索莱宝
电话:010-50973130拨打
手机:18101056239 拨打
邮箱:3193328036@qq.com

产品详情:

中文名称:
Anti-CPEB4 (N-term) Polyclonal Antibody
英文名称:
Anti-CPEB4 (N-term) Polyclonal Antibody
Public Immunogen Range:
synthetic peptide between 109-137 amino acids
Subcellular Locations:
Cytoplasm Cell membrane
Swiss Prot:
Q17RY0
保存:
Store at -20°C. Avoid freeze / thaw cycles.
别名:
CPEB4 (N-term)
产品编号:
K006384P
储存液:
Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
纯化方法:
Affinity purification
蛋白分子量:
80kDa
克隆类型:
Polyclonal Antibody
免疫原:
synthetic peptide between 109-137 amino acids
宿主:
Rabbit
稀释比例:
WB 1:1000. IHC 1:50-100.
性状:
液体
亚型:
Ig
应用:
WB IHC-P
英文名称:
Anti-CPEB4 (N-term) Polyclonal Antibody

背景资料

Sequence-specific RNA-binding protein that binds to the cytoplasmic polyadenylation element (CPE), an uridine-rich sequence element (consensus sequence 5'-UUUUUAU-3') within the mRNA 3'-UTR (PubMed:24990967). RNA binding results in a clear conformational change analogous to the Venus fly trap mechanism (PubMed:24990967). Regulates activation of unfolded protein response (UPR) in the process of adaptation to ER stress in liver, by maintaining translation of CPE-regulated mRNAs in conditions in which global protein synthesis is inhibited (By similarity). Required for cell cycle progression, specifically for cytokinesis and chromosomal segregation (PubMed:26398195). Plays a role as an oncogene promoting tumor growth and progression by positively regulating translation of t-plasminogen activator/PLAT (PubMed:22138752). Stimulates proliferation of melanocytes (PubMed:27857118). In contrast to CPEB1 and CPEB3, does not play role in synaptic plasticity, learning and memory (By similarity).
Anti-CPEB4 (N-term) Polyclonal Antibody;抗体

公司简介

北京索莱宝科技有限公司是一家集研发、生产、销售、服务于一体的高科技生物企业。技术推广;技术转让;技术咨询;技术服务;生物试剂技术开发;销售生物试剂盒、实验室专用化学试剂、实验室专用设备、办公用品、化工产品(不含危险化学品)、计算机软件及辅助设备;货物进出口、技术进出口、代理进出口;委托加工生产生物制品、生化制品、化工产品(不含危险化学品);生产生物试剂盒;批发第一类医疗器械、第二类医疗器械;批发第三类医疗器械。

成立日期 (22年)
注册资本 4001万元
员工人数 100-500人
年营业额 ¥ 500万-1000万
经营模式 贸易,工厂,试剂
主营行业 分析化学,生物化工,化学试剂,医药原料,仪器耗材

Anti-CPEB4 (N-term) Polyclonal Antibody相关厂家报价

内容声明
拨打电话 立即询价